a month ago
ASND
AnalystsAlex ThompsonAlex Thompson's Stock Forecasts
AnalystsAlex Thompson
Sectors:
Industries:
Analyst Ranking
Top 14%
#687 out of 5177 analysts
Average Return
+16.86%
Win Rate
64%25 out of 39
Risk vs Reward
Poor
Good
Alex Thompson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dice Therapeutics IncDICE | +126.21% | $21.02 | $47.55 | 2022-09-07 - 2023-08-08 | Strong Buy |
Kymera Therapeutics IncKYMR | +126.21% | $31.44 | $71.12 | 2025-05-20 - 2026-01-15 | Strong Buy |
Chinook Therapeutics IncKDNY | +110.51% | $17.99 | $37.87 | 2022-06-28 - 2023-06-13 | Strong Buy |
Immunovant IncIMVT | +108.86% | $15.47 | $32.31 | 2023-03-30 - 2024-03-28 | Strong Buy |
Spyre Therapeutics IncSYRE | +108.11% | $14.75 | $30.69 | 2023-07-25 - 2024-07-24 | Strong Buy |
Alex Thompson Analyst Color
Get additional color on Alex Thompson's coverage of popular stocks
a month ago
ARGX
3 months ago
ANAB
4 months ago
DNTH
a year ago
ASND
2 years ago
ARGX
2 years ago
SYRE
2 years ago
SYRE
2 years ago
ACRS
2 years ago
IMVT
3 years ago
ARGX
3 years ago
KDNY
Alex Thompson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ascendis Pharma AASND | 4 | Strong Buy | $256.00 | +19.05% | Maintains | a month ago |
Argenx SeARGX | 5 | Strong Buy | $1,248.00 | +53.46% | Maintains | a month ago |
Anaptysbio IncANAB | 2 | Strong Buy | $56.00 | +20.92% | Maintains | a month ago |
Dianthus Therapeutics IncDNTH | 2 | Strong Buy | $65.00 | +47.73% | Maintains | 4 months ago |
Travere Therapeutics IncTVTX | 4 | Hold | $25.00 | -11.97% | Maintains | 4 months ago |
Cullinan Therapeutics IncCGEM | 1 | Strong Buy | $22.00 | +106.38% | Reinstates | 7 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $55.00 | -22.67% | Reinstates | 8 months ago |
Third Harmonic Bio IncTHRD | 2 | Hold | $5.00 | -7.06% | Downgrades | 10 months ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $36.00 | +130.18% | Initiates Coverage On | 10 months ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Strong Buy | $60.00 | +6.33% | Initiates Coverage On | 10 months ago |
Oruka Therapeutics IncORKA | 1 | Strong Buy | $49.00 | N/A | Initiates Coverage On | a year ago |
Morphic Holding IncMORF | 4 | Hold | $57.00 | N/A | Maintains | a year ago |
Spyre Therapeutics IncSYRE | 3 | Strong Buy | $54.00 | N/A | Reiterates | 2 years ago |
Ventyx Biosciences IncVTYX | 5 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Strong Buy | $69.00 | N/A | Maintains | 2 years ago |
Aclaris Therapeutics IncACRS | 4 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Viridian Therapeutics IncVRDN | 2 | Strong Buy | $40.00 | N/A | Reiterates | 2 years ago |
Rapt Therapeutics IncRAPT | 1 | Strong Buy | $320.00 | N/A | Initiates Coverage On | 2 years ago |
Immunovant IncIMVT | 2 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $41.00 | N/A | Downgrades | 3 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 3 years ago |
Dice Therapeutics IncDICE | 1 | Strong Buy | $37.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.